The Hypothalamic Glucagon-Like Peptide 1 Receptor Is Sufficient but Not Necessary for the Regulation of Energy Balance and Glucose Homeostasis in Mice
Open accessThe DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
Pharmacological activation of the hypothalamic glucagon-like peptide 1 (GLP-1) receptor (GLP-1R) promotes weight loss and improves glucose tolerance. This demonstrates that the hypothalamic GLP-1R is sufficient but does not show whether it is necessary for the effects of exogenous GLP-1R agonists (GLP-1RA) or endogenous GLP-1 on these parameters. To address this, we crossed mice harboring floxed Glp1r alleles to mice expressing Nkx2.1-Cre to knock down Glp1r expression throughout the hypothalamus (GLP-1RKDΔNkx2.1cre). We also generated mice lacking Glp1r expression specifically in two GLP-1RA–responsive hypothalamic feeding nuclei/cell types, the paraventricular nucleus (GLP-1RKDΔSim1cre) and proopiomelanocortin neurons (GLP-1RKDΔPOMCcre). Chow-fed GLP-1RKDΔNkx2.1cre mice exhibited increased food intake and energy expenditure with no net effect on body weight. When fed a high-fat diet, these mice exhibited normal food intake but elevated energy expenditure, yielding reduced weight gain. None of these phenotypes were observed in GLP-1RKDΔSim1cre and GLP-1RKDΔPOMCcre mice. The acute anorectic and glucose tolerance effects of peripherally dosed GLP-1RA exendin-4 and liraglutide were preserved in all mouse lines. Chronic liraglutide treatment reduced body weight in chow-fed GLP-1RKDΔNkx2.1cre mice, but this effect was attenuated with high-fat diet feeding. In sum, classic homeostatic control regions are sufficient but not individually necessary for the effects of GLP-1RA on nutrient homeostasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“our data suggest that key drug-accessible GLP1R populations outside of the hindbrain (including vagal afferents and the hypothalamus45) are dispensable for their therapeutic effects”
From Dissociable hindbrain GLP1R circuits for satiety and aversion (2024) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639 · cited 1×
“Glucagon-like peptide 1 (GLP-1) is a gut-secreted peptide that augments glucose-dependent insulin secretion via a pancreatic GLP-1 receptor (GLP-1R) (1).”
BackgroundSelf-citationA role for glucagon-like peptide-1 in the central regulation of feeding
Turton, M. D., O'Shea, D., Gunn, I., Beak, S. A., Edwards, C. M. B., Meeran, K., Choi, S. J., Taylor, G. M., Heath, M. M., Lambert, P. D., et al. (1996) · Nature · doi:10.1038/379069a0 · Cited by 1,950
Divergence of Melanocortin Pathways in the Control of Food Intake and Energy Expenditure
Balthasar, N., Dalgaard, L. T., Lee, C. E., Yu, J., Funahashi, H., Williams, T., Ferreira, M., Tang, V., McGovern, R. A., Kenny, C. D., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.035 · Cited by 1,120
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
Secher, A., Jelsing, J., Baquero, A. F., Hecksher-Sørensen, J., Cowley, M. A., Dalbøge, L. S., Hansen, G., Grove, K. L., Pyke, C., Raun, K., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci75276 · Cited by 961 · cited 9×
“ICV delivery of the GLP-1R antagonist exendin (9-39) (Ex9) stimulates food intake in fed rats and blocks the anorectic effects of peripherally”
BackgroundMethodInfluentialLeptin receptor signaling in POMC neurons is required for normal body weight homeostasis
Balthasar, N., Coppari, R., McMinn, J., Liu, S. M., Lee, C. E., Tang, V., Kenny, C. D., McGovern, R. A., Chua, S. C., Elmquist, J. K., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.06.004 · Cited by 935
GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK
Beiroa, D., Imbernon, M., Gallego, R., Senra, A., Herranz, D., Villarroya, F., Serrano, M., Fernø, J., Salvador, J., Escalada, J., et al. (2014) · Diabetes · doi:10.2337/db14-0302 · Cited by 602 · cited 4×
“This is surprising because ICV or hypothalamic administration of GLP-1RA increases EE (15,43).”
BackgroundMethodInfluentialCentral administration of GLP-1-(7-36) amide inhibits food and water intake in rats
Tang-Christensen, M., Larsen, P. J., Goke, R., Fink-Jensen, A., Jessop, D. S., Moller, M., & Sheikh, S. P. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.4.r848 · Cited by 597
Interactions of Glucagon-Like Peptide-1 (GLP-1) with the Blood-Brain Barrier
Kastin, A. J., Akerstrom, V., & Pan, W. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:18:1-2:07 · Cited by 480
Yamamoto, H., Lee, C. E., Marcus, J., Williams, T. D., Overton, J. M., Lopez, M. E., Hollenberg, A. N., Baggio, L. L., Saper, C. B., Drucker, D. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15595 · Cited by 473
Self-citationYamamoto, H., Lee, C. E., Marcus, J. N., Williams, T. D., Overton, J. M., Lopez, M. E., Hollenberg, A. N., Baggio, L., Saper, C. B., Drucker, D. J., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215595 · Cited by 429
Self-citation
Cited by
Items 101–134 of 134
Incretin Hormones in the Control of Immunometabolism
Fishman, S., Zvibel, I., & Varol, C. (2019) · Immunometabolism · doi:10.20900/immunometab20190004 · Cited by 6
Meier, M., Cummings, J. L., Abdelsaid, M. A., Feliciano, J., Eusebe, J., Stirn, H., & Coucha, M. M. (2026) · Kidney Medicine · doi:10.1016/j.xkme.2026.101282 · Cited by 7
Uncovering the role of Gpr45 in obesity regulation
Karolczak, E. O., Li, C., Alcantara, I. C., Cohen, I. M., Gao, C., Xiao, C., Goldschmidt, A. I., Pinkus, C. A., Li, J., Li, M. M., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102174 · Cited by 9
Zhou, M., Du, M., Tang, R., Liu, H., Gao, Z., Wang, Y., You, H., Hao, J.-W., Ji, Z., Wang, D., et al. (2023) · Neuroendocrinology · doi:10.1159/000529438 · Cited by 5
Failor, M., Bohler, M., Cao, C. Q., Gilbert, E. R., & Cline, M. A. (2023) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2023.114292 · Cited by 4
Morais, T., Patrício, B. G., Pereira, S. S., Andrade, S., Carreira, M. C., Casanueva, F. F., & Monteiro, M. P. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28719 · Cited by 5
Singh, I., Wang, L., Xia, B., Liu, J., Tahiri, A., Ouaamari, A. E., Wheeler, M. B., & Pang, Z. P. (2022) · Research Square · doi:10.21203/rs.3.rs-1971723/v1 · Cited by 4
Cassano, D., Aguggia, J. P., Giovanini, L., Heredia, F., Francesco, P. N. D., Andreoli, M. F., Schöth, H. B., Habib, A. M., Fernández, G., & Perelló, M. (2025) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2025.112627 · Cited by 3
Phan, C., & Wagner, E. J. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.11.038 · Cited by 4
Review on the role of hypothalamic astrocytes in the neuroendocrine control of metabolism
Farhadi, Z., Khaksari, M., Alivirdiloo, V., Mehrjerdi, F. Z., Alborzi, N., Baktash, K. B., & Rezvani, M. E. (2024) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-024-01465-9 · Cited by 4
Profiling human hypothalamic neurons reveals a candidate combination drug therapy for weight lossPreprint
Chen, H. C., Yang, A., Mazzaferro, S., Mali, I. D., Cahn, O., Kentistou, K. A., Rowley, C., Stewart, N. M., Seah, J. W. E., Pisupati, V., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.18.549357 · Cited by 4
Individual paraventricular hypothalamic GLP-1R neurons track ingestion across energy states
Savani, R. H., Wang, L., Lu, Y., Le, T., Park, E., Yang, M., Pang, Z. P., & Rossi, M. A. (2025) · iScience · doi:10.1016/j.isci.2025.114070 · Cited by 2
Sui, K., Yasrebi, A., Malonza, N., Jaffri, Z. H., Fisher, S. E., Seelenfreund, I., McGuire, B. D., Martinez, S. A., MacDonell, A. T., Tveter, K. M., et al. (2023) · Endocrinology · doi:10.1210/endocr/bqad059 · Cited by 4
Yang, G., Burgess, S., & Schooling, C. M. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04244-7 · Cited by 3
Le, T. D. V., Fathi, P. A., Watters, A. B., Ellis, B. J., Bozadjieva-Kramer, N., Perez, M. B., Sullivan, A. I., Rose, J. P., Baggio, L. L., Koehler, J. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.03.522509 · Cited by 2
Self-citationObesity and Atrial Fibrillation: Therapeutic Perspective for GLP-1 Analogs
Szołkiewicz-Płatkowska, A., & Orczykowski, M. (2024) · In a good rythm · doi:10.5604/01.3001.0054.6436 · Cited by 1
Zhang, C., Wang, Z. M., Jiang, Z.-J., Kim, H., Liu, C., & Wang, H. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1838267 · Cited by 2
The central amygdala gates exogenous glucagon-like peptide 1 signals
Duran, M., Zeng, N., Cutts, E. J., POLAMARASETTY, A., Rodríguez, M., Habegger, K. M., & Hardaway, J. A. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102403 · Cited by 2
Devi, S., Gedda, D., Chawla, S., Doucette, J. A., Yadav, N., Mirshahi, S., de Moura, L. P., Velloso, L. A., & Mekary, R. A. (2022) · International Journal of Neuroscience · doi:10.1080/00207454.2022.2086127 · Cited by 1
Yu, H., Feng, N., Zhong, W., Han, Y., Cheng, Y., Zhang, Z., Wang, Y., Gao, P., Huang, R., Zhang, C., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202402546r · Cited by 2
Endocrine Mechanisms in Obesity
Fischer, K., & Müller, T. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54852-6.00013-6
Generation and use of new tools for the characterisation of gut hormone receptors
Biggs, E. K. (2018) · Apollo (University of Cambridge) · doi:10.17863/cam.37487
Glucocorticoid Action in the Mediobasal Hypothalamus Regulates Glucose Production In Vivo
Beaulieu-Bayne, E. (2019) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-eahb-a894
Münzberg, H. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734472367.793574569
Gene regulating effects of Cymbopogon citratus on glucose metabolism of normal albino rats
Joshua, A. A., Onoagbe, I. O., & Omonkhua, A. A. (2022) · International Journal for Biotechnology and Molecular Biology Research · doi:10.5897/ijbmbr2022.0328
Суплотова, Л. А., Fedorova, A. I., Kulmametova, D. S., Сергеевна, Д. Т., & Makarova, O. B. (2023) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2022-16-23-148-155
Modder, M., Tomás, A., Afkir, S., Pronk, A. C. M., Streefland, T. C. M., Lalai, R. A., van Eenige, R., Rensen, P. C. N., Jones, B. J., & Kooijman, S. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16374
Yang, W., Yang, Z., Lu, S., Meng, L., Yang, F., Liu, H., & Wang, J. (2026) · Experimental Brain Research · doi:10.1007/s00221-026-07274-1
Des toxines animales comme ligands innovants des récepteurs aux mélanocortines
Reynaud, S. (2019) · theses.fr (ABES) · doi:10.70675/3b7e4bedz99ffz4cbaz82c0za19291184a87
The central amygdala integrates exogenous glucagon-like peptide 1 signalsPreprint
Duran, M., Zeng, N., Cutts, E. J., Habegger, K. M., & Hardaway, J. A. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.06.716705
Discovery of a new GLP-1 receptor agonist using DNA encoded-libraries and similarity search
Lee, J. H., Kim, D., Jeon, H., Park, S. B., Koh, B., Lim, B., Lee, K. A., Choi, K. J., Kim, S. S., Kwon, Y., et al. (2026) · Results in Chemistry · doi:10.1016/j.rechem.2026.103415 · Cited by 1
Murugadoss, K., Venkatakrishnan, A., & Soundararajan, V. (2026) · npj Metabolic Health and Disease · doi:10.1038/s44324-026-00131-3
Metadata
- Authors
- Burmeister, M. A., Ayala, J. E., Smouse, H., Landivar-Rocha, A., Brown, J. D., Drucker, D. J., Stoffers, D. A., Sandoval, D. A., Seeley, R. J., & Ayala, J. E.
- Affiliations
- Sanford Burnham Prebys Medical Discovery Institute (US)
- Mount Sinai Hospital (CA)
- University of Pennsylvania (US)
- Michigan Medicine (US)
- Corresponding author
- Burmeister, Melissa A.
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2016-12-01
- Volume
- 66
- Issue
- 2
- Pages
- 372-384
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC5248999
- OpenAlex
- W2557682509
- Cited by
- 136
- References
- 51
- Citations by year
- 2026: 9 · 2025: 19 · 2024: 13 · 2023: 13 · 2022: 15 · 2021: 10 · 2020: 16 · 2019: 14 · 2018: 20 · 2017: 7
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (123391)
- National Institutes of Health (7R01DK082480, 1R01DK107652, 4R01DK097361)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- GLP-1 receptor, hypothalamus, energy balance, glucose homeostasis, paraventricular nucleus, proopiomelanocortin neurons, exendin-4, liraglutide, GLP-1 receptor agonists, dietary intake, energy expenditure, high-fat diet, weight loss, glucose tolerance
- MeSH terms
- Glucagon-Like Peptide-1 Receptor, Liraglutide, Exenatide, Animals, Body Composition, Eating, Energy Metabolism, Glucose, Glucose Tolerance Test, Homeostasis, Hypothalamus, Male, Neurons, Paraventricular Hypothalamic Nucleus, Peptides, Pro-Opiomelanocortin, Venoms, Weight Gain, Mice, Glucagon-Like Peptide 1, Incretins, Gene Knockdown Techniques, Diet, High-Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.